We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Light-Induced Immunoassay Selectively Detects Coronavirus Spike Proteins In 5 Minutes

By LabMedica International staff writers
Posted on 19 Sep 2024

Like moths drawn to a flame, microbes can also be influenced by light. More...

Using this principle, researchers have developed a method to quickly detect viruses using only a small sample.

Scientists at Osaka Metropolitan University's Research Institute for Light-induced Acceleration System (RILACS) have developed a light-induced immunoassay for virus detection. By applying laser irradiation for less than a minute, they used a nanoparticle-imprinted plasmonic substrate with nanobowl structures (each 500 nm in diameter) coated with antibodies for the spike proteins of the novel coronavirus. A low-power 5-milliwatt laser, similar to commercial laser pointers, was able to form bubbles on the biochip that attracted virus-mimicking nanoparticles, speeding up the selective detection of these particles.

The process works because light-induced convection causes the nanoparticles to move and gather at a stagnant region between the substrate surface and the bottom of the bubble, meaning a high particle concentration isn't necessary. The entire procedure—from coating the substrate to detecting the virus—can be completed in under 5 minutes, as reported in the journal npj Biosensing.

“This study shows that we can shorten the cumbersome antibody coating process and perform rapid and highly sensitive protein detection,” said OMU Professor Takuya Iida, the director of RILACS. “We believe our findings can contribute to the early diagnosis of not only the novel coronavirus, but possibly also various infectious diseases, cancer, even dementia.”

Related Links:
RILACS


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Enterovirus Test
Quanty Enterovirus System
New
Giardia Assay
AccuDiag Giardia
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.